Using immunofluorescent digital slide technology to quantify protein expression in archival paraffin-embedded tissue...

Area of Science:

• Pathology
• Biotechnology
• Cancer Research

Background:

• Accurate molecular expression assessment is crucial for molecularly targeted cancer therapies.
• Immunohistochemistry (IHC) is standard for scoring receptors like HER2, but its quantification is controversial.
• Virtual slide technology enables rapid digitization of immunofluorescence whole slide images.

Purpose of the Study:

• To establish and validate fluorescence-based, immunofluorescent quantification digital slides (IQD) for routine cancer molecular expression assessment.
• To compare the accuracy and reliability of IQD with conventional IHC scoring.
• To address the challenges in quantifying protein expression intensity in IHC.

Main Methods:

• Formalin-fixed, paraffin-embedded tissue sections were scanned to create IQD, incorporating morphological and immunofluorescent data.
• Image analysis software was used to assess protein expression on IQD.
• IQD scores were statistically correlated with IHC scores for HER2 and steroid receptors.

Main Results:

• A statistically significant correlation was found between IQD and IHC scores for HER2 and steroid receptors.
• IQD analysis revealed no significant statistical difference between IHC intermediate-expression groups and high or negative-expression groups.
• The study demonstrated the applicability of IQD in routine practice for molecular assessment.

Conclusions:

• Immunofluorescent quantification digital slides (IQD) provide a robust method for quantifying molecular markers in cancer.
• IQD can assist pathologists in accurately assessing protein expression, potentially resolving IHC scoring ambiguities.
• This digital approach enhances the reliability of molecular diagnostics for targeted cancer therapies.